We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GB.WS
9026
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$206 ﹤0.01%
+2,579
New +$170
BLEUU
9027
DELISTED
bleuacacia ltd Unit
BLEUU
$200 ﹤0.01%
20
PBL icon
9028
PGIM Portfolio Ballast ETF
PBL
$78.1M
$199 ﹤0.01%
7
-63
-90% -$1.73K
AEVAW
9029
DELISTED
Aeva Technologies Warrants
AEVAW
$198 ﹤0.01%
7,915
+7,757
+4,909% +$367
YOLO icon
9030
AdvisorShares Pure Cannabis ETF
YOLO
$29.8M
$196 ﹤0.01%
58
-6,900
-99% -$26.5K
FTHM icon
9031
Fathom Holdings
FTHM
$26.4M
$193 ﹤0.01%
112
KTTA icon
9032
Pasithea Therapeutics
KTTA
$15.4M
$192 ﹤0.01%
38
-570
-94% -$3.72K
MBND icon
9033
State Street Nuveen Municipal Bond ETF
MBND
$26.8M
$192 ﹤0.01%
+7
New +$191
GORV
9034
DELISTED
Lazydays
GORV
$191 ﹤0.01%
3
-250
-99% -$26.5K
XLO icon
9035
Xilio Therapeutics
XLO
$59.9M
$191 ﹤0.01%
14
CINGW icon
9036
Cingulate Inc Warrants
CINGW
$47.1K
$187 ﹤0.01%
17,035
+16,949
+19,708% +$292
MMVWW
9037
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$185 ﹤0.01%
+7,388
New +$266
BIVI icon
9038
BioVie
BIVI
$11.5M
$184 ﹤0.01%
5
-219
-98% -$10.5K
MARX
9039
DELISTED
Mars Acquisition Corp. Ordinary Shares
MARX
$184 ﹤0.01%
17
ESLAW icon
9040
Estrella Immunopharma Warrant
ESLAW
$210K
$183 ﹤0.01%
+5,090
New +$265
ATIP
9041
DELISTED
ATI Physical Therapy, Inc.
ATIP
$183 ﹤0.01%
41
-593
-94% -$2.74K
UPXI icon
9042
Upexi
UPXI
$55.5M
$181 ﹤0.01%
+25
New +$238
LTRX icon
9043
Lantronix
LTRX
$240M
$178 ﹤0.01%
50
-2,483
-98% -$8.9K
CCRD
9044
DELISTED
CoreCard
CCRD
$175 ﹤0.01%
12
-8,451
-100% -$111K
UTHY icon
9045
US Treasury 30 Year Bond ETF
UTHY
$174M
$175 ﹤0.01%
+4
New +$174
MSSAW
9046
DELISTED
Metal Sky Star Acquisition Corporation Warrant
MSSAW
$175 ﹤0.01%
+13,431
New +$176
WINVW
9047
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$173 ﹤0.01%
+12,384
New +$215
GNPX icon
9048
Genprex
GNPX
$3.02M
-1
Closed -$2.69K
SHRT icon
9049
Gotham Short Strategies ETF
SHRT
$15M
$172 ﹤0.01%
+22
New +$178
BATL icon
9050
Battalion Oil
BATL
$31.9M
$170 ﹤0.01%
51

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.